Abstract:IMPORTANCE Psychiatric disorders display high levels of comorbidity and genetic overlap, necessitating multivariate approaches for parsing convergent and divergent psychiatric risk pathways. Identifying gene expression patterns underlying cross-disorder risk also stands to propel drug discovery and repurposing in the face of rising levels of polypharmacy. OBJECTIVE To identify gene expression patterns underlying genetic convergence and divergence across psychiatric disorders along with existing pharmacological interventions that target these genes. DESIGN, SETTING, AND PARTICIPANTS This genomic study applied a multivariate transcriptomic method, transcriptome-wide structural equation modeling (T-SEM), to investigate gene expression patterns associated with 5 genomic factors indexing shared risk across 13 major psychiatric disorders. Follow-up tests, including overlap with gene sets for other outcomes and phenome-wide association studies, were conducted to better characterize T-SEM results. The Broad Institute Connectivity Map Drug Repurposing Database and Drug-Gene Interaction Database public databases of drug-gene pairs were used to identify drugs that could be repurposed to target genes found to be associated with cross-disorder risk. Data were collected from database inception up to February 20, 2023. MAIN OUTCOMES AND MEASURES Gene expression patterns associated with genomic factors or disorder-specific risk and existing drugs that target these genes. RESULTS In total, T-SEM identified 466 genes whose expression was significantly associated (z >= 5.02) with genomic factors and 36 genes with disorder-specific effects. Most associated genes were found for a thought disorders factor, defined by bipolar disorder and schizophrenia. Several existing pharmacological interventions were identified that could be repurposed to target genes whose expression was associated with the thought disorders factor or a transdiagnostic p factor defined by all 13 disorders. CONCLUSIONS AND RELEVANCE The findings from this study shed light on patterns of gene expression associated with genetic overlap and uniqueness across psychiatric disorders. Future versions of the multivariate drug repurposing framework outlined here have the potential to identify novel pharmacological interventions for increasingly common, comorbid psychiatric presentations.

Advancing Mental Health Research Through Strategic Integration of Transdiagnostic Dimensions and Genomics

Psychiatric genomics, mental health equity, and intersectionality: A framework for research and practice

Psychiatric Neuroimaging at a Crossroads: Insights from Psychiatric Genetics

Bioinformatics in Psychiatric Genetics

Genetic tests in major psychiatric disorders—integrating molecular medicine with clinical psychiatry—why is it so difficult?

Genome-wide Association Study of Dimensional Psychopathology Using Electronic Health Records.

Integrating Polygenic Allele Burden Information and Phenomic Data to Characterize Complex Disease Trajectories in Severe Mental Illness

Genetic Insights into Externalizing and Internalizing Traits through Integration of the Research Domain Criteria and Hierarchical Taxonomy of Psychopathology

Shared Molecular Neuropathology Across Major Psychiatric Disorders Parallels Polygenic Overlap

Transcriptome-Wide Structural Equation Modeling of 13 Major Psychiatric Disorders for Cross-Disorder Risk and Drug Repurposing

Genetic Analysis of Deep Phenotyping Projects in Common Disorders

Combining Transdiagnostic and Disorder-Level GWAS Enhances Precision of Psychiatric Genetic Risk Profiles in a Multi-Ancestry Sample

Trends in big data analyses by multicenter collaborative translational research in psychiatry

Towards a consensus roadmap for a new diagnostic framework for mental disorders

Leveraging the Genetics of Psychiatric Disorders to Prioritize Potential Drug Targets and Compounds

NIMH perspectives on future directions in neuroimaging for mental health

BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders

T-SEM of 11 Major Psychiatric Disorders: Identification of Gene Expression Patterns for Cross-Disorder Risk and Drug Repurposing

Genes in context: path to more precise risk prediction in psychiatry?

The Psychiatric Cell Map Initiative: A Convergent Systems Biological Approach to Illuminating Key Molecular Pathways in Neuropsychiatric Disorders

Leveraging pleiotropy for the improved treatment of psychiatric disorders